Galapagos NV | Large-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 65.3M
Gross Profit 60.6M 92.79%
Operating Income -57.0M -87.35%
Net Income -105.7M -161.97%

Balance Sheet Metrics

Total Assets 4.0B
Total Liabilities 1.3B
Shareholders Equity 2.7B
Debt to Equity 0.46

Cash Flow Metrics

Operating Cash Flow -43.0M
Free Cash Flow -43.9M

Revenue & Profitability Trend

Galapagos NV Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i275.6M239.7M241.2M234.4M478.1M
Cost of Goods Sold i34.9M-12.1M1.6M0
Gross Profit i240.8M-493.2M483.2M478.1M
Gross Margin % i87.4%0.0%204.4%206.2%100.0%
Operating Expenses
Research & Development i335.5M241.3M269.8M320.5M523.7M
Selling, General & Administrative i96.9M94.3M103.3M89.2M158.0M
Other Operating Expenses i-16.4M-23.6M-9.4M-20.2M-30.3M
Total Operating Expenses i416.0M311.9M363.7M389.6M651.4M
Operating Income i-188.3M-88.3M-131.1M-171.6M-178.6M
Operating Margin % i-68.3%-36.8%-54.3%-73.2%-37.4%
Non-Operating Items
Interest Income i89.8M79.6M18.1M2.9M10.0M
Interest Expense i911.0K1.8M9.2M11.6M9.4M
Other Non-Operating Income95.8M16.3M51.5M61.5M-116.3M
Pre-tax Income i-3.1M5.6M-70.8M-119.4M-309.8M
Income Tax i-1.8M9.6M572.0K1.4M1.2M
Effective Tax Rate % i0.0%170.9%0.0%0.0%0.0%
Net Income i74.1M211.7M-218.0M-103.2M-305.4M
Net Margin % i26.9%88.3%-90.4%-44.0%-63.9%
Key Metrics
EBITDA i-52.5M34.8M-47.6M-134.6M-165.4M
EPS (Basic) i€1.12€3.21€-3.32€-1.58€-4.69
EPS (Diluted) i€1.12€3.21€-3.32€-1.58€-4.69
Basic Shares Outstanding i6614464365884000656599406550000065075000
Diluted Shares Outstanding i6614464365884000656599406550000065075000

Income Statement Trend

Galapagos NV Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i64.2M166.8M508.1M2.2B2.1B
Short-term Investments i3.1B3.5B3.6B2.5B3.0B
Accounts Receivable i32.5M17.5M28.2M91.8M134.6M
Inventory i51.2M74.0M52.9M20.6M355.0K
Other Current Assets--2.0K-1.0K-
Total Current Assets i3.3B3.9B4.2B4.9B5.4B
Non-Current Assets
Property, Plant & Equipment i8.6M6.8M11.6M60.3M37.3M
Goodwill i304.9M267.0M286.0M60.1M67.6M
Intangible Assets i164.9M127.9M146.4M60.1M67.6M
Long-term Investments-----
Other Non-Current Assets179.9M148.2M127.1M133.7M168.5M
Total Non-Current Assets i796.3M495.8M497.5M331.3M348.4M
Total Assets i4.1B4.4B4.7B5.2B5.7B
Liabilities
Current Liabilities
Accounts Payable i97.8M134.7M133.3M134.3M171.3M
Short-term Debt i3.5M4.7M7.2M7.2M6.4M
Current Portion of Long-term Debt-----
Other Current Liabilities5.0K32.0M8.5M204.0K12.1M
Total Current Liabilities i335.1M428.2M522.5M566.5M635.3M
Non-Current Liabilities
Long-term Debt i8.2M4.9M14.7M19.7M23.0M
Deferred Tax Liabilities i20.7M23.6M20.1M00
Other Non-Current Liabilities33.8M31.6M21.8M7.1M8.1M
Total Non-Current Liabilities i903.7M1.1B1.7B2.0B2.4B
Total Liabilities i1.2B1.6B2.2B2.5B3.0B
Equity
Common Stock i293.9M293.9M293.6M292.1M291.3M
Retained Earnings i-134.3M-228.3M-496.7M-367.2M-334.7M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.9B2.8B2.5B2.6B2.7B
Key Metrics
Total Debt i11.7M9.6M21.9M26.9M29.4M
Working Capital i3.0B3.4B3.7B4.3B4.7B

Balance Sheet Composition

Galapagos NV Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i74.1M211.7M-218.0M-103.2M-305.4M
Depreciation & Amortization i45.5M43.6M65.6M34.6M18.7M
Stock-Based Compensation i19.9M56.7M88.5M70.7M80.0M
Working Capital Changes i-320.6M-692.4M-351.3M-430.4M-353.9M
Operating Cash Flow i-300.6M-460.4M-439.5M-407.1M-542.3M
Investing Activities
Capital Expenditures i-16.7M-16.3M-26.6M-54.2M-42.5M
Acquisitions i-8.9M-7.0M-115.3M28.7M0
Investment Purchases i-3.4B-3.4B-2.7B-1.6B-4.6B
Investment Sales i3.7B3.5B1.6B2.1B5.4B
Investing Cash Flow i256.5M57.0M-1.2B544.9M802.6M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-4.9M-6.8M-8.2M-7.2M-6.2M
Financing Cash Flow i-4.9M-5.0M-1.5M-3.9M22.0M
Free Cash Flow i-402.1M-425.2M-537.5M-561.7M-518.7M
Net Change in Cash i-49.0M-408.4M-1.7B133.9M282.4M

Cash Flow Trend

Galapagos NV Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 51.71
Forward P/E -41.14
Price to Book 0.72
Price to Sales 6.89
PEG Ratio -41.14

Profitability Ratios

Profit Margin -103.14%
Operating Margin -87.35%
Return on Equity -10.39%
Return on Assets -5.11%

Financial Health

Current Ratio 8.08
Debt to Equity 0.32
Beta 0.03

Per Share Data

EPS (TTM) €-4.38
Book Value per Share €40.12
Revenue per Share €4.18

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
glpga1.9B51.710.72-10.39%-103.14%0.32
Pharming Group N.V 841.3M57.153.45-3.70%-2.41%53.57
Vivoryon 43.5M-2.0713.87-145.47%0.00%2.26
Koninklijke Philips 22.7B150.002.201.51%0.91%80.96
ASML Holding N.V 328.6B33.7117.8358.25%29.27%21.00
Shell plc 181.5B15.961.007.54%5.00%41.33

Financial data is updated regularly. All figures are in the company's reporting currency.